Top

Published in:

01-06-2010 | Key Note Lecture

Is chronic migraine a primary or a secondary condition?

Authors: Vincenzo Bonavita, Roberto De Simone

Published in: Neurological Sciences | Special Issue 1/2010

Abstract

In the light of the pathophysiologic knowledge acquired in recent years, a tentative redefinition of some types of headache, until now defined as primary, is now possible. Chronic migraine is proposed here as the consequence of “processes” to be ascribed to mechanisms activated by comorbid conditions. The observations supporting the possibility that allodynia represents the process leading to pain progression, which occurs in some migraineurs, are discussed.

Bonavita V, De Simone R (2009) Redefining primary headaches. Neurol Sci 30(Suppl 1):S1–S5PubMedCrossRef

Headache Classification Subcommittee of the International Headache Society (2004) International classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):1–160

Bonavita V, De Simone R (2008) Towards a definition of comorbidity in the light of clinical complexity. Neurol Sci 29(Suppl 1):S99–S101PubMedCrossRef

Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875PubMed

Olesen J, Rasmussen BK (1996) The international headache society classification of chronic daily and near-daily headaches: a critique of the criticism. Cephalalgia 16:407–411PubMedCrossRef

Headache Classification Committee, Olesen J, Bousser MG et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746PubMedCrossRef

Olesen J (2007) Reply: new appendix criteria open for a broader concept of chronic migraine. Cephalalgia 27:469–470CrossRef

Silberstein SD, Olesen J, Bousser MG et al (2005) The international classification of headache disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 medication-overuse headache. Cephalalgia 25:460–465PubMedCrossRef

Lance F, Parkes C, Wilkinson M (1988) Does analgesic abuse cause headaches de novo? Headache 28:61–62PubMedCrossRef

10.

Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190PubMedCrossRef

11.

Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190–196PubMedCrossRef

12.

Colás R, Muñoz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse. Epidemiology and impact on quality of life. Neurology 62:1338–1342PubMed

13.

Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66:1894–1898PubMedCrossRef

14.

Reuter U, Salomone S, Ickenstein GW, Waeber C (2004) Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia 24:398–407PubMedCrossRef

15.

Dobson CF, Tohyama Y, Diksic M, Hamel E (2004) Effects of acute or chronic administration of antimigraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalagia 24:2–11CrossRef

16.

Fumal A, Laureys S, Di Clemente L et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543–550PubMedCrossRef

17.

Ayzenberg I, Obermann M, Nyhuis P et al (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26:1106–1114PubMedCrossRef

18.

Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703–1709PubMedCrossRef

19.

Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55(1):19–26PubMedCrossRef

20.

Ashkenazi A, Sholtzow M, Shaw JW, Burstein R, Young WB (2007) Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia 27:111–117PubMedCrossRef

21.

Cooke L, Eliasziw M, Becker WJ (2007) Cutaneous allodynia in transformed migraine patients. Headache 47(4):531–539PubMed

22.

Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2006) Frequency of headache is related to sensitization: a population study. Pain 123(1–2):19–27PubMedCrossRef

23.

Bigal ME, Ashina S, Burstein R et al (2008) Prevalence and characteristics of allodynia in headache sufferers. A population study. Neurology 70:1525–1533PubMedCrossRef

24.

Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2007) Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study. Pain 137(3):623–630PubMedCrossRef

25.

Filatova E, Latysheva N, Kurenkov A (2008) Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain 9:295–300PubMedCrossRef

26.

Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276PubMedCrossRef

27.

Scher AI, Midgette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48:16–25PubMedCrossRef

28.

Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache 46(9):1334–1343PubMedCrossRef

29.

De Simone R, Ranieri A, Fiorillo C, Bilo L, Bonavita V (2010) Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression? Neurol Sci. doi:10.1007/s10072-010-0229-1

30.

Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66(4):545–550PubMedCrossRef

31.

Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106(1–2):81–89PubMedCrossRef

32.

Bigal ME, Lipton RB, Holland PR, Goadsby PJ (2007) Obesity, migraine, and chronic migraine. Possible mechanisms of interaction. Neurology 68:1851–1861PubMedCrossRef

33.

Silberstein SD, Lipton RB, Breslau N (1995) Migraine: association with personality characteristics and psychopathology. Cephalalgia 15:358–369PubMedCrossRef

34.

Radat F, Swendsen J (2005) Psychiatric comorbidity in migraine: a review. Cephalalgia 25:165–178PubMedCrossRef

35.

Frediani F, Villani V (2007) Migraine and depression. Neurol Sci 28(Suppl):S161–S165PubMedCrossRef

36.

Breslau N, Lipton RB, Stewart WF et al (2003) Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60:1308–1312PubMed

37.

Zwart JA, Dyb G, Hagen K et al (2003) Depression and anxiety disorders associated with headache frequency. The nord-trondelag health study. Eur J Neurol 10:147–152PubMedCrossRef

38.

Radat F, Creac’h C, Swendsen JD et al (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25:519–522PubMedCrossRef

39.

Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample. Headache 38:497–506PubMedCrossRef

40.

Stewart WF, Scher AI, Lipton RB (2001) The frequent headache epidemiology study (FrHE): stressful life events and risk of chronic daily headache. Neurology 56:A138–A139

41.

Houle T, Nash JM (2008) Stress and headache chronification. Headache 48:40–44PubMedCrossRef

42.

Wang SJ, Fuh JL, Lu SR, Juang KD (2007) Outcomes and predictors of chronic daily headache in adolescents. A 2-year longitudinal study. Neurology 68:591–596PubMedCrossRef

43.

Luconi R, Bartolini M, Taffi R et al (2007) Prognostic significance of personality profiles in patients with chronic migraine. Headache 47:1118–1124PubMedCrossRef

44.

Gazerani P, Andersen OK, Arendt-Nielsen L (2005) A human experimental capsaicin model for trigeminal sensitization: gender-specific differences. Pain 118:155–163PubMedCrossRef

45.

Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495PubMed

46.

Lipton HL, Michelson PE (1972) Pseudotumor cerebri syndrome without papilledema. JAMA 220:1591–1592PubMedCrossRef

47.

Marcelis J, Silberstein SD (1992) Idiopathic intracranial hypertension without papilledema. Arch Neurol 48:392–399

48.

Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230PubMed

49.

Vieira DS, Masruha MR, Gonçalves AL et al (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28:609–613PubMedCrossRef

50.

De Simone R, Marano E, Bilo L et al (2006) Idiopathic intracranial hypertension without headache. Cephalalgia 26(8):1020–1021PubMedCrossRef

51.

Farb RI, Vanek I, Scott JN et al (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMed

52.

King JO, Mitchell PJ, Thomson KR, Tress BM (1995) Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 45:2224–2228PubMed

53.

Karakalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198–202

54.

Doepp F, Schreiber SJ, Dreier JP et al (2003) Migraine aggravation caused by cephalic venous congestion. Headache 43:96–98PubMedCrossRef

55.

Chou CH, Chao AC, Lu SR et al (2004) Cephalic venous congestion aggravates only migraine-type headaches. Cephalalgia 24:973–979PubMedCrossRef

56.

Truini A, Cruccu G (2006) Pathophysiological mechanisms of neuropathic pain. Neurol Sci 27:S179–S182PubMedCrossRef

57.

Giesbrecht RJ, Battié MC (2005) A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 85:1085–1092PubMed

58.

Obermann M, Yoon MS, Ese D et al (2007) Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69:835–841PubMedCrossRef

59.

Ashina S, Babenko L, Jensen R et al (2005) Increased muscular and cutaneous pain sensitivity in cephalic region in patients with chronic tension-type headache. Eur J Neurol 12:543–549PubMedCrossRef

60.

Staud R, Spaeth M (2008) Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia. CNS Spectr 13(Suppl 5):12–17PubMed

61.

Schwartzman RJ, Alexander GM, Grothusen J (2006) Pathophysiology of complex regional pain syndrome. Expert Rev Neurother 6:669–681PubMedCrossRef

Title: Is chronic migraine a primary or a secondary condition?
Authors: Vincenzo Bonavita
Roberto De Simone
Publication date: 01-06-2010
Publisher: Springer Milan
Published in: Neurological Sciences / Issue Special Issue 1/2010
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-010-0272-y

2024 ASCO Annual Meeting

Springer Medicine

Is chronic migraine a primary or a secondary condition?

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2010

Migraine and vertigo: two diseases with the same pathogenesis?

Persistent idiopathic facial pain: multidisciplinary approach and assumption of comorbidity

Fabry disease in patients with migraine with aura

Clinical considerations on chronic migraine, pharmacoresistance and refractoriness

Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis

The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline